SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Intelgenx(IGXT) MC $54M /2 NDA Submission withn 3 months
IGXT 0.1670.0%May 27 5:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFileNext 10PreviousNext  
From: BioHero6/23/2017 10:18:31 AM
   of 4
 
Heavily undervalued stock with so many big milestones on the way

Market cap $55 million

Upcoming Milestones:

NDA submission for tadalafil (erectile dysfunction) thin-film version of Blockbuster drug Cialis in June or July

NDA resubmission for Rizaport (migraine) in early Q3

Start Phase 2a of Montelukast (Alzheimer Disease ) potential Blockbuster

Partnership for Tadalafil could come anytime now

Partnership for Rizaport for EU and USA could also happen anytime now

Monster Pipeline
s2.q4cdn.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFileNext 10PreviousNext